Early Data With Olaratumab in Soft Tissue Sarcoma
3 意见
• 07/18/23
0
0
嵌入
The panelists, Brian Van Tine, MD, PhD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD; discuss phase I/II data with olaratumab and its mechanism of action.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论